Clinical Trial Update: Bone Response to Enzyme Replacement in Gaucher's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bone response to enzyme replacement therapy in Gaucher's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Gaucher's Disease | Phase 2 | Status: COMPLETED